BENSULFOID Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Bensulfoid, and what generic alternatives are available?
Bensulfoid is a drug marketed by Poythress and is included in one NDA.
The generic ingredient in BENSULFOID is sulfur. There are two drug master file entries for this compound. Additional details are available on the sulfur profile page.
Summary for BENSULFOID
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 37 |
Patent Applications: | 33 |
Formulation / Manufacturing: | see details |
DailyMed Link: | BENSULFOID at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for BENSULFOID
US Patents and Regulatory Information for BENSULFOID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Poythress | BENSULFOID | sulfur | POWDER;TOPICAL | 002918-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |